Sunshine Biopharma, Inc. SBFM
2.35 USD -0.06 (-2.49%)
Regular-session close
2.35 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
2.33 Day range 2.42
2.33 52-week range 464.00
- YTD
- -99.04%
- 1 year
- -99.17%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 36.31M | 34.87M | 24.09M | 4.35M | 228.43K | |
| 12.26M | 10.67M | 8.34M | 1.70M | 110.60K | |
| -6.23M | -5.81M | -4.79M | -27.00M | -2.44M | |
| -5.98M | -5.13M | -4.51M | -26.74M | -12.44M | |
| -288.00 | -1,464.00 | -70,272.00 | -704,000.00 | -1,904,000.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 9.12M | 9.69M | 16.29M | 21.83M | 2.05M | |
| 30.08M | 30.56M | 27.35M | 29.24M | 2.20M | |
| 7.04M | 7.06M | 6.14M | 7.62M | 1.99M | |
| 812.42K | 952.48K | 657.71K | 765.26K | 1.90M | |
| 23.04M | 23.50M | 21.21M | 21.63M | 211.66K |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -5.33M | -12.52M | -8.78M | -5.25M | -1.83M | |
| -836.31K | -1.98M | -656.15K | -14.62M | 0 | |
| 4.75M | 8.94M | 3.43M | 39.47M | 2.90M | |
| -174.49K | -1.66M | 49.70K | -160.60K | 0 | |
| -1.42M | -5.56M | -6.01M | 19.60M | 1.08M |
